vimarsana.com
Home
Live Updates
ASPIVIX SA: CLINICAL DATA SHOW SIGNIFICANTLY LOWER IUD PROCE
ASPIVIX SA: CLINICAL DATA SHOW SIGNIFICANTLY LOWER IUD PROCE
ASPIVIX SA: CLINICAL DATA SHOW SIGNIFICANTLY LOWER IUD PROCEDURAL PAIN AND BLEEDING RATES WITH ASPIVIX'S NOVEL SUCTION-BASED CERVICAL DEVICE
GHENT, Belgium, May 25, 2022 /PRNewswire/ -- ASPIVIX SA, a developer of medical technologies to advance gynecological care, today announced positive results from its ADVANCE Women (Atraumatic
Related Keywords
Geneva ,
Genè ,
Switzerland ,
Renens ,
Switzerland General ,
United States ,
Belgium ,
Andrea Albornoz ,
Kostenloser Wertpapierhandel ,
Michal Yaron ,
Mathieu Horras ,
Geneva University Hospitals ,
Department Of Woman ,
Reproductive Health ,
European Society Of Contraception ,
Le Service De La Promotion ,
European Union ,
Lausanne University Hospital ,
Atraumatic Device ,
Intrauterine Device ,
European Society ,
Outpatient Gynecology Consultations ,
Geneva University ,
Chief Executive Officer ,
Database Syst ,
Aspivix ,
Linical ,
Data ,
Show ,
Ignificantly ,
Tower ,
Procedural ,
Rain ,
Bleeding ,
Rates ,
Ith ,
Novel ,
Auction ,
Ased ,
Cervical ,
Device ,